Overview
Polycaprolactone-Chitosan (PCL-CS) is a biodegradable polymer blend combining the mechanical resilience of polycaprolactone (PCL) with the bioactivity and antimicrobial properties of chitosan (CS). Developed to address limitations of single-component materials, PCL-CS is extensively researched for biomedical applications due to its tunable degradation rate and compatibility with human tissues. The blend leverages PCL's hydrophobic nature and CS's hydrophilic properties, enabling tailored release profiles for drugs or growth factors. Its versatility supports fabrication into films, fibers, and porous scaffolds, making it a cornerstone material in regenerative medicine and controlled-release technologies.
Physical and Chemical Properties
PCL-CS exhibits a semi-crystalline structure dominated by PCL's crystalline domains, while CS introduces amorphous regions enhancing water absorption and degradation. The blend's mechanical properties (e.g., tensile strength: 10–40 MPa) depend on the PCL:CS ratio, with higher PCL content increasing elasticity and CS improving rigidity. Degradation occurs via hydrolysis (PCL) and enzymatic action (CS), with rates adjustable from weeks to years. CS's cationic nature provides inherent antimicrobial activity, while PCL ensures structural integrity during early-stage implantation. The blend is stable at room temperature but degrades at high temperatures (>200°C).
Main Applications
In drug delivery, PCL-CS microspheres or films enable sustained release of therapeutics (e.g., antibiotics, anticancer drugs), leveraging CS's pH-responsive behavior for targeted delivery. Tissue engineering utilizes its scaffold-forming ability to support cell adhesion and growth, particularly in bone and cartilage regeneration. Wound dressings benefit from CS's hemostatic and antibacterial properties combined with PCL's barrier function. Recent advances include 3D-printed PCL-CS constructs for customized implants. The blend is also explored in food packaging (active coatings) and agricultural films (controlled-release fertilizers).
Safety and Storage
PCL-CS is generally recognized as safe (GRAS) for biomedical use, with no cytotoxic effects reported in standard assays. However, residual solvents (e.g., from processing) must be minimized per ISO 10993 standards. Dust inhalation during handling should be avoided using PPE. Storage requires protection from humidity (CS is hygroscopic) and UV light to prevent premature degradation. Bulk material should be sealed in moisture-proof bags with desiccants. Sterilized grades (gamma-irradiated or ethylene oxide-treated) are recommended for surgical applications.
B2B Procurement Guide
Key specifications for procurement include blend ratio (common ratios: 70:30 to 90:10 PCL:CS), molecular weight distribution, and endotoxin levels (<0.25 EU/mg for implants). Suppliers may offer custom modifications (e.g., crosslinking, composite additives). Pricing varies by scale, with bulk orders (100+ kg) often discounted. Lead times depend on formulation complexity (2–8 weeks). Certifications (e.g., USP, ISO 13485) are critical for medical-grade material. Sample testing for batch consistency is advised, particularly for mechanical performance and sterility.
Related Manufacturers
- 主营：[]
- 主营：金纳米、三角片、麦芽糖、壳聚糖、羟丙基、ito薄膜、氮化钛、tio2纳米、碳粉tio2、修饰tio2、pd纳米笼、水溶伊红、纳米复合、磁性纳米、蛋白芯片、包硅金银、硅纳米线、包硅纳米、硅纳米管、螯合树脂、油溶性银、复合材料、薄膜定制、纳米粒子